A Phase I, First-in-Human clinical trial of AB 101 (Insulin) in subjects with type 1 diabetes mellitus.
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; First in man
- Sponsors Rezolute
- 07 Dec 2017 According to a AntriaBio media release, AntriaBio changed its name to Rezolute.
- 25 Jul 2017 According to an AntriaBio media release, Following the completion of the first part of the study, the company expects to review data and announce high-level results as early as Q4 2017.
- 25 Jul 2017 According to an AntriaBio media release, first patient has been dosed.